Home » Topics » Regulatory » Patents

Patents
RSS

New antipsychotics discovered at Duphar

Dec. 30, 1997

Pfizer claims NOS inhibitors for CNS and inflammatory disorders

Dec. 30, 1997

Cephalon describes new indolocarbazoles for prostate disorders

Dec. 30, 1997

New treatment approach for nasal congestion

Dec. 30, 1997

Merck & Co.'s newest D4 antagonists possess potent antipsychotic activity

Dec. 30, 1997

Boehringer Mannheim presents new calcium regulators

Dec. 30, 1997

New antiinflammatory compounds disclosed by Glycomed

Dec. 30, 1997

Otsuka's new antidiabetic agents

Dec. 29, 1997

New antiallergic agents from Dainippon Ink & Chemicals

Dec. 29, 1997

SS Pharm. patents new antifungal agents

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...